Skip to main content

Table 3 Positive bacterial culture results from sterile sites at onset and during the course of prolonged meropenem therapy

From: Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-control study

Intraoperative cultures (abdominal, thoracic) blood cultures CSF, brain tissue
Enterococcus faecium, n = 7
Enterococcus faecalis, n = 6
Stenotrophomonas maltophilia, n = 6
multidrug-resistant, carbapenem-susceptible Escherichia coli, n = 2a
Enterobacter cloacae complex, n = 2
Coagulase-negative staphylococci, n = 2
Pseudomonas aeruginosa, n = 1
Proteus mirabilis, n = 1
Proteus vulgaris, n = 1
Klebsiella pneumoniae, n = 1
Escherichia coli (non MRGN), n = 1
Staphylococcus aureus, n = 1
Enterococcus gallinarum, n = 1
E. faecalis, n = 1
E. faecium, n = 1
Vancomycin-resistant Enterococcus faecium, n = 1
E. aerogenes, n = 1
E. cloacae, n = 1
S. maltophilia, n = 1
multidrug-resistant, carbapenem-resistant P.aeruginosa, n = 1
Staphylococcus aureus, n = 1
Staphylococcus epidermidis, n = 1
Proteus mirabilis, n = 1
Bacteroides fragilis, n = 1
  1. aisolates that require unequivocally carbapenem therapy
  2. Abbreviations: n number of patients; CSF cerebrospinal fluid